Jump Financial’s C4 Therapeutics CCCC Stock Holding History

Jump Financial’s Portfolio CCCC Stock Details CCCC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$853K	Buy	+182,700	New	+$625K	0.01%	1254
2024 Q4	–	Sell	-134,636	Closed	-$767K	–	1680
2024 Q3	$767K	Sell	134,636 -88,564	-40%	-$533K	0.02%	916
2024 Q2	$1.03M	Buy	223,200 +106,693	+92%	+$636K	0.02%	801
2024 Q1	$952K	Buy	+116,507	New	+$903K	0.03%	831
2023 Q3	–	Sell	-17,915	Closed	-$49.3K	–	1877
2023 Q2	$49.3K	Buy	+17,915	New	+$57.6K	﹤0.01%	1724
2023 Q1	–	Sell	-36,000	Closed	-$212K	–	1633
2022 Q4	$212K	Buy	+36,000	New	+$298K	0.01%	1254
2022 Q3	–	Sell	-18,721	Closed	-$141K	–	1623
2022 Q2	$141K	Buy	18,721 +2,921	+18%	+$25.7K	0.01%	1385
2022 Q1	$383K	Sell	15,800 -18,189	-54%	-$442K	0.02%	942
2021 Q4	$1.09M	Sell	33,989 -5,711	-14%	-$226K	0.07%	365
2021 Q3	$1.77M	Buy	+39,700	New	+$1.7M	0.13%	175

Other funds holding CCCC

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

LCM

Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return

SCM

Squadron Capital Management Westmont, Illinois $322M AUM

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Jump Financial's CCCC Position: Q2 2026 in Review

Jump Financial opened a new position in C4 Therapeutics (CCCC) in Q2 2026: 182,700 shares worth $853K. The stake represents 0.01% of the portfolio and ranks #1254 among its holdings. This is a return to the name: Jump Financial previously reported a position in CCCC as recently as Q3 2024.

Jump Financial first reported a position in CCCC in Q3 2021 and has held it in 10 quarters since. The position peaked at $1.77M in Q3 2021. 147 funds tracked by Wall St. Rank hold CCCC as of Q2 2026.

Jump Financial held 182,700 shares of C4 Therapeutics worth $853K as of Q2 2026.
C4 Therapeutics was a new Jump Financial position in Q2 2026.
C4 Therapeutics made up 0.01% of Jump Financial's portfolio in Q2 2026, its #1254 holding.
Jump Financial first reported a position in C4 Therapeutics in Q3 2021 and has held it in 10 quarters since.
Jump Financial's C4 Therapeutics position peaked at $1.77M in Q3 2021.
147 funds tracked by Wall St. Rank held C4 Therapeutics as of Q2 2026.

Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.